Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate Mofetil in MN and FSGS
NCT00404833Phase 3Completed
- Sponsor
- Hospital Authority
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mycophenolate mofetil in idiopathic membranous nephropathy (IMN), focal segmental glomerulosclerosis (FSGS), sponsored by Hospital Authority. Started Jan 2003; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
idiopathic membranous nephropathy (IMN)focal segmental glomerulosclerosis (FSGS)
Beyond the preview
Go deeper on NCT00404833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404833.